Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.
about
Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studiesDexamethasone as a probe for vinorelbine clearance.Oral versus intravenous vinorelbine: clinical safety profile.Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
P2860
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacokinetic linearity of i ...... dose escalation study design.
@en
Pharmacokinetic linearity of i ...... dose escalation study design.
@nl
type
label
Pharmacokinetic linearity of i ...... dose escalation study design.
@en
Pharmacokinetic linearity of i ...... dose escalation study design.
@nl
prefLabel
Pharmacokinetic linearity of i ...... dose escalation study design.
@en
Pharmacokinetic linearity of i ...... dose escalation study design.
@nl
P2093
P1476
Pharmacokinetic linearity of i ...... dose escalation study design.
@en
P2093
Alain Goupil
Christian Puozzo
David Khayat
Jean-Luc Harousseau
Norbert Ifrah
René Brunet
Roland Bugat
P2888
P304
P356
10.1007/S00280-004-0794-1
P50
P577
2004-05-25T00:00:00Z
P6179
1009854194